Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Mise à jour : Il y a 4 ans
Référence : NCT02425111

Femme et Homme

Extrait

The purpose of this study is to evaluate endoscopic remission at Week 26 as assessed by ileocolonoscopy.


Critère d'inclusion

  • Crohn’s Disease


Liens